1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor-agnostic precision immuno-oncology and somatic targeting rationale for you (TAPISTRY): A novel platform umbrella trial
    Meeting Abstract

    Drilon, A. E.; Liu, H. Y.; Wu, F.; Chen, D.; Wilson, T. R.; Simmons, B. P.; Barlesi, F.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers
    Meeting Abstract

    Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy
    Meeting Abstract

    Lavery, J. A.; Brown, S.; Riely, G. J.; Bedard, P. L.; Park, B. H.; Warner, J. L.; Kehl, K. L.; Lepisto, E. M.; Rizvi, H.; LeNoue-Newton, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Oncologist management of NTRK fusion-positive NSCLC improves after virtual patient simulation participation
    Meeting Abstract

    Worst, M. A.; Cain, B.; Nelson, T.; Cohen, J.; Drilon, A. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies
    Meeting Abstract

    Murciano-Goroff, Y. R.; Schram, A. M.; Rosen, E.; Janjigian, Y. Y.; Berger, M. F.; Donoghue, M.; Bandlamudi, C.; Drilon, A. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events
    Meeting Abstract

    Luo, J.; Beattie, J.; Fuentes, P.; Rizvi, H.; Egger, J. V.; Kern, J.; Leung, D. Y. M.; Lacouture, M. E.; Kris, M. G.; Gambarin, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors
    Meeting Abstract

    Sarfaty, M.; Desjardins, C. A.; Giardina, P.; Bardhan, K.; Pandian, S.; Halley, K.; Halvorsen, E. M.; Callahan, M. K.; Postow, M. A.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Ricciuti, B.; Rizvi, H.; Hellmann, M. D.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; Rudin, C. M.; Lito, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy
    Meeting Abstract

    Offin, M.; Egger, J. V.; McCarthy, C. G.; Rudneva, V.; Beattie, J.; Ginsberg, M. S.; Sauter, J. L.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save